id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-3305-0001,FDA,FDA-2016-E-3305,Patent Extension Application from Foley & Lardner LLP (on behalf of Provepharm S.A.S.),Other,Application,2016-10-13T04:00:00Z,2016,10,2016-10-13T04:00:00Z,,2016-10-13T15:15:44Z,,0,0,09000064822ee88a
FDA-2016-E-3305-0002,FDA,FDA-2016-E-3305,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-10-13T04:00:00Z,2016,10,2016-10-13T04:00:00Z,,2016-10-13T15:15:49Z,,0,0,09000064822ee992